ArticleAmerican journal of cancer research2025
Efficacy and influencing factors of immunotherapy crossover combined with targeted therapy in advanced esophageal cancer patients following first-line chemotherapy combined with immunotherapy failure.
Xiuxiu Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.